Partners Sinergy


The Universitat Autònoma de Barcelona (UAB) is one of the major public universities of Spain. It is located in Bellaterra, close to Barcelona. Currently, the University offers 87 bachelor’s degrees, covering a wide range of fields such as humanities and arts, social sciences, health sciences, technology and physical sciences. Furthermore, the UAB offers 133 Master’s degrees, as well as 8 Erasmus Mundus Master’s degrees; more than 1,114 PhD dissertations have been elaborated within its doctoral programs. The University has over 37,700 students, almost 3,700 researchers and teaching staff, and it hosts more than 6,000 foreign students.

Thus, the UAB is among the leading Spanish universities in world rankings such as the QS World University Rankings (QS WUR), the Times Higher Education World University Rankings (THE WUR) and the Academic Ranking of World Universities (ARWU), and occupies a world leading position among young universities according to specific classifications.

According to the Ranking QS WUR 2018, which classifies the 500 best universities in the world, the UAB is considered as the third university in Spain and is ranked 195th worldwide (and 89th in Europe).

The UAB is the 2nd Spanish university in the ranking THE WUR 2018 and the 2nd Spanish university by volume of publications indexed in SCOPUS according to the ranking of the research activity SIR WR 2014.



Lund University (ULUND) was founded in 1666. Today, with eight faculties and a number of research centers and institutes, Lund University is one of the largest high education units in Scandinavia. The university has been ranked among the top 100 universities worldwide, and it is the highest ranked university in Sweden in the QS Ranking 2016/2017. At present, more than 42,000 students are enrolled at Lund University, and altogether some 7,400 faculty staffs are employed. The University has a turnover of around SEK 8 billion (EUR 800 million), of which two thirds is in research and one third in education. The university cooperates with 600 partner universities in over 70 countries, and it is the only Swedish university to be a member of the strong international networks LERU (the League of European Research Universities) and Universitas 21. Lund University has worldleading research facilities. Two of the world’s foremost research facilities for materials research and life sciences are established in Lund – the synchrotron radiation facility MAX IV, which was inaugurated in June 2016, and the European Spallation Source (ESS) which will feature the world’s most powerful neutron source when it opens for research in 2023. The Division of Pure and Applied Biochemistry (LPAB) is a part of the Center for Chemistry and Chemical Engineering, one of the largest chemical centers worldwide. The Division, with about 30 full-time researchers and technical personnel, is mainly active in scientific areas related to molecular recognition, bioseparation technology, genetic engineering, biosensors, functional polymers and biointerfaces, biomaterials and nanobiotechnology.


The University of Pau and Pays de l’Adour(UPPA) was founded in 1972. It is a multi-site establishment, based in Pau but also in Bayonne, Tarbes and Mont-de-Marsan in the Adour river basin. Coming administratively under the Academy of Bordeaux, it is the third largest university in southwestern France, with some 12.000 students. University of Pau and Pays de l’Adour annually hosts nearly 60 foreign faculty members and over 1.400 international students from Europe and around the world: North America, South America, Africa, Asia and Oceania. With 80.191 Erasmus agreements, interuniversity cooperation worldwide bilateral agreements UPPA participates in exchanges of students, teachers and researchers internationally. Due to its geographical situation, particularly UPPA develops original border university cooperation with Spain as well as in the field of teaching research.

The institute that will be participating in RECOPHARMA will be IPREM “Institut des Sciences Analytiques et de Physicochimie pour l’Environnement et les Matériaux” a mixt research unit, specifically through the LCABIE (Laboratoire de ChimieAnalytiqueBioinorganiqueetEnvironnement). The LCABIE, 30 permanent scientists is mainly conducting research on speciation and isotopic analysis of trace metals in order to contribute to the understanding of biogeochemical cycles and environmental impacts of trace elements and metals in the environment. The laboratory has been pioneering novel approaches to unravel the distribution and fate of metals and metalloid species between different compartments of the environment for more than 20 years. Most of the developments have been achieved by hyphenation techniques using either LC or GC coupled to a variety of detectors. To ascertain the quality of the environmental results, the laboratory has been also developing reference materials, novel sample preparation techniques and speciated isotopic dilution methods to improve both precision and accuracy in environmental determination.



The University of Udine (UNIUD) was founded in 1978 as part of the reconstruction plan of Friuli after the earthquake in 1976. Its aim was to provide the Friulian community with an independent centre for advanced training in cultural and scientific studies.Currently, the University of Udine offers 36 first cycle degree courses and 35 second cycle degree courses. In addition, the University offers postgraduate teaching and research, with a broad and diverse range of training courses, specialization schools (19), university master (6) and doctorate (12) degrees. It has 15.635 students and 678 professorsand researchers. Scientific research is performed and coordinated by 14 Departments and 8 interdepartmental centers and supported by a central administrative office. UNIUD has been involved as partner in many different EU research projects:

  • FP7: 38 projects, three of which coordinated;
  • Other international: 20 projects, 7 of which coordinated;
  • Territorial cooperation (Interreg): 29 projects, 2 of which coordinated.

UNIUD has competent personnel in administration, economy, legal and planning. The technical and scientific activities are developed with the support of the research and technology transfer office. This office manages complex projects, protects intellectual property and transfers research results to the local area. The structure is supported by a team of 13 specificallytrained employees, who have long-time experiences in coordination and planning leadership.


AERIS Tecnologías Ambientales, S.L., Spain (AERIS) ( SPAIN

TecnologíasAmbientales, S.L. (AERIS) is a spin-off of the Autonomous University of Barcelona constituted by experts from the GENOCOV research group (UAB)whose main activity is the design and industrial implementation of biological reactors for air and water treatment.

Among this second line, one of its principal business areas is the optimization of the biological and/or physico-chemical depuration of industrial liquid streams containing significant amounts of recalcitrant compounds. In this field, numerous R+D and technological implementation projects have been carried out in the last years, mostly in paperproducing, tannery and food industries.

Europe For Business (EFB) ( UNITED KINGDOM

Set up in 2007, Europe for Business Ltd.(EFB) is a high-growth knowledge intensive company, doubling its turnover each year and expanding its operation in the whole Europe. The growth of EFB can be explained by the innovative and specific services that the company offers, by supporting Industrial and Research organisations in defining and implementing their innovation and research strategies, through the usage of advanced methodologies, communication and dissemination strategies, promotional tools and ICT  and IT solutions oriented.

Headquartered in London EFB, is made up of a pool of professional engineers with consolidated experience in international working environments (Europe, Latin America and, USA) and Grant Advisors specialized in consultancy services for grants submission and negotiation, project management, and dissemination actions.


University of Habana (UH) was founded in 1728. It has18 faculties, 14 research centers, 1700 professors and researchers.PhD 630, master’s 562, 68% of staff hold PhD or master’s degrees. UH has4.200 international students, 19.945 students, 66 Master’s Programs, Joint Curricular PHD Programs 15, Accredited Master’s Programs 39 and 29 Curricular PHD Programs in Groups. More than 440 agreements signed, participates in international exchange programs, e.g US Semesters Programs, EU ERASMUS MUNDUS PROGRAMS (4), more than 50 international networks and 93 international organizations and associations. UH is the Cuban institution with the greatest scientific production.

Concentrates near 1/3 of the prizes awarded by the Academy of Sciences of Cuba, ranked fifth in the viability index of national patents. Scientific production frontier close to 1,200 articles and more than 100 books a year. UH has more than 10 institutional academic and scientific networks on priority topics. Regarding international cooperation projects, it is prioritized by UH authorities and an office of international project management has been created.262 international projects are running right now and more than 3 million USD per year comes to UH from International Cooperation Projects, it is connected with more than 60 Universities from 25 Countries, and receives found from more than 96 international agencies.



Founded in 1992,CenterOf Drugs Research And Development Of Pharmaceuticals(CIDEM) is part of the scientific centers of the Pharmaceutical and Biotechnical Cuban Industry and has developed important pharmaceutical products starting from own technologies, which integrate the therapeutic arsenal of the country. It has 7 facilities complemented by a quality system allowing environment sustenance starring in two major health programs for the development and introduction of generic drugs and natural products (herbal). CIDEM is recognized by the country as a leader in these two subjects. The cytostatic drugs development is one of the most important research lines focused on cancer problems in Cuba. Previous results obtained in this area made possible the construction in 2002 of the unique cytostatics drugs plant in Cuba subordinated to CIDEM. CIDEM apply the concept of closed cycle research results to their heath record, with own production out-put or introduction in the pharmaceutical industry. It has a role in the drug policy of the National Health and Herbal medicine. It has more than 460 workers and 350 of them are linked to the research and development sector. Directs Journal of Pharmacy, is the Board of Cuban Medicinal Plants, a member of the Board of Directors of the Cuban Society of Pharmacy.